Talis Biomedical Corporation (TLIS)
USD 1.74
(8.75%)
USD 1.74
(8.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 412 Thousand USD | -88.72% |
| 2022 | 3.65 Million USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 10.93 Million USD | 175.03% |
| 2019 | 3.97 Million USD | 66.4% |
| 2018 | 2.39 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 73 Thousand USD | -51.66% |
| 2024 Q2 | - USD | -100.0% |
| 2023 Q4 | 151 Thousand USD | 98.68% |
| 2023 FY | 412 Thousand USD | -88.72% |
| 2023 Q1 | 137 Thousand USD | 28.04% |
| 2023 Q2 | 48 Thousand USD | -64.96% |
| 2023 Q3 | 76 Thousand USD | 58.33% |
| 2022 Q2 | 502 Thousand USD | -78.3% |
| 2022 FY | 3.65 Million USD | 0.0% |
| 2022 Q4 | 107 Thousand USD | -85.34% |
| 2022 Q3 | 730 Thousand USD | 45.42% |
| 2022 Q1 | 2.31 Million USD | 1061109.17% |
| 2021 Q4 | -218.00 USD | -200.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q3 | 218.00 USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 FY | 10.93 Million USD | 175.03% |
| 2020 Q4 | 10.93 Thousand USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2019 FY | 3.97 Million USD | 66.4% |
| 2019 Q4 | 1.5 Million USD | 0.0% |
| 2018 FY | 2.39 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 94.249% |
| Cerus Corporation | 156.36 Million USD | 99.737% |
| OrthoPediatrics Corp. | 148.73 Million USD | 99.723% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | 57.469% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 97.015% |
| Inogen, Inc. | 315.66 Million USD | 99.869% |
| Spectral AI, Inc. | 18.05 Million USD | 97.718% |
| Nano-X Imaging Ltd. | 9.9 Million USD | 95.84% |
| CVRx, Inc. | 39.29 Million USD | 98.952% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | 36.025% |
| Orthofix Medical Inc. | 746.64 Million USD | 99.945% |
| Venus Concept Inc. | 76.35 Million USD | 99.46% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | 96.583% |
| Bioventus Inc. | 512.34 Million USD | 99.92% |
| BrainsWay Ltd. | 31.78 Million USD | 98.704% |
| Envoy Medical, Inc. | 316 Thousand USD | -30.38% |
| electroCore, Inc. | 16.03 Million USD | 97.43% |
| IceCure Medical Ltd | 3.22 Million USD | 87.241% |
| Lucid Diagnostics Inc. | 2.42 Million USD | 83.031% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -12.877% |
| MaxCyte, Inc. | 41.28 Million USD | 99.002% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | 78.898% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -272.016% |
| PAVmed Inc | 2.45 Million USD | 83.197% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 98.17% |
| RxSight, Inc. | 89.07 Million USD | 99.537% |
| Sight Sciences, Inc. | 81.05 Million USD | 99.492% |
| SI-BONE, Inc. | 138.88 Million USD | 99.703% |
| TELA Bio, Inc. | 58.45 Million USD | 99.295% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 97.774% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 99.78% |
| LivaNova PLC | 1.15 Billion USD | 99.964% |
| 908 Devices Inc. | 50.22 Million USD | 99.18% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 99.915% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -434.759% |
| NeuroPace, Inc. | 65.42 Million USD | 99.37% |
| LENSAR, Inc. | 42.16 Million USD | 99.023% |
| Apyx Medical Corporation | 52.34 Million USD | 99.213% |
| Cutera, Inc. | 212.36 Million USD | 99.806% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 98.765% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2188.889% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 99.753% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 98.28% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.973% |
| Axonics, Inc. | 366.37 Million USD | 99.888% |
| Outset Medical, Inc. | 130.37 Million USD | 99.684% |
| IRIDEX Corporation | 51.86 Million USD | 99.206% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 99.697% |
| IRadimed Corporation | 65.56 Million USD | 99.372% |
| Tivic Health Systems, Inc. | 1.17 Million USD | 64.966% |
| INVO Bioscience, Inc. | 3.02 Million USD | 86.36% |
| Telesis Bio, Inc. | 27.5 Million USD | 98.502% |
| Viemed Healthcare, Inc. | 183 Million USD | 99.775% |
| Varex Imaging Corporation | 811 Million USD | 99.949% |
| Quipt Home Medical Corp. | 221.74 Million USD | 99.814% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 99.4% |
| Dynatronics Corporation | 32.53 Million USD | 98.734% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | 95.252% |
| Semler Scientific, Inc. | 68.18 Million USD | 99.396% |
| InMode Ltd. | 492.04 Million USD | 99.916% |
| Bruker Corporation | 2.96 Billion USD | 99.986% |
| Cytosorbents Corporation | 36.34 Million USD | 98.867% |
| DexCom, Inc. | 3.62 Billion USD | 99.989% |
| Align Technology, Inc. | 3.86 Billion USD | 99.989% |
| Viveve Medical, Inc. | 6.42 Million USD | 93.589% |
| ZimVie Inc. | 457.43 Million USD | 99.91% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 99.787% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -272.016% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.945% |
| Profound Medical Corp. | 7.33 Million USD | 94.38% |
| Insulet Corporation | 1.69 Billion USD | 99.976% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 99.673% |
| iCAD, Inc. | 17.31 Million USD | 97.621% |
| Nuwellis, Inc. | 8.86 Million USD | 95.352% |
| Biotricity, Inc. | 12.06 Million USD | 96.585% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 99.916% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | 93.36% |
| PAVmed Inc. | 2.45 Million USD | 83.197% |
| BIOLASE, Inc. | 49.16 Million USD | 99.162% |
| Beyond Air, Inc. | 1.15 Million USD | 64.452% |
| FONAR Corporation | 102.88 Million USD | 99.6% |
| AxoGen, Inc. | 159.01 Million USD | 99.741% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 99.85% |
| Inari Medical, Inc. | 493.63 Million USD | 99.917% |
| UFP Technologies, Inc. | 400.07 Million USD | 99.897% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -2115.054% |
| Tenon Medical, Inc. | 2.92 Million USD | 85.929% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | 93.952% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.987% |
| Sintx Technologies, Inc. | 2.62 Million USD | 84.317% |
| NanoVibronix, Inc. | 2.28 Million USD | 81.954% |
| Quanterix Corporation | 122.36 Million USD | 99.663% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 98.312% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.795% |
| TransMedics Group, Inc. | 241.62 Million USD | 99.829% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 97.026% |
| NeuroMetrix, Inc. | 5.9 Million USD | 93.019% |
| Hyperfine, Inc. | 11.03 Million USD | 96.265% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 99.751% |
| Biomerica, Inc. | 5.41 Million USD | 92.392% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 99.185% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 99.767% |